| Literature DB >> 23795343 |
Aniket S Wadajkar1, Jyothi U Menon, Tejaswi Kadapure, Richard T Tran, Jian Yang, Kytai T Nguyen.
Abstract
Recently, magnetic-based theranostic nanoparticle (MBTN) systems have been studied, researched, and applied extensively to detect and treat various diseases including cancer. Theranostic nanoparticles are advantageous in that the diagnosis and treatment of a disease can be performed in a single setting using combinational strategies of targeting, imaging, and/or therapy. Of these theranostic strategies, magnetic-based systems containing magnetic nanoparticles (MNPs) have gained popularity because of their unique ability to be used in magnetic resonance imaging, magnetic targeting, hyperthermia, and controlled drug release. To increase their effectiveness, MNPs have been decorated with a wide variety of materials to improve their biocompatibility, carry therapeutic payloads, encapsulate/bind imaging agents, and provide functional groups for conjugation of biomolecules that provide receptor-mediated targeting of the disease. This review summarizes recent patents involving various polymer coatings, imaging agents, therapeutic agents, targeting mechanisms, and applications along with the major requirements and challenges faced in using MBTN for disease management.Entities:
Keywords: hyperthermia; imaging agents; magnetic nanoparticles; polymeric shell; theranostics; therapeutic agents
Year: 2013 PMID: 23795343 PMCID: PMC3686518 DOI: 10.2174/1874764711306010007
Source DB: PubMed Journal: Recent Pat Biomed Eng ISSN: 1874-7647